This morning, Johnson & Johnson shared its 2024 first-quarter earnings report.
Since its founding in 1886 the company has been committed to innovation—today, more than 130,000 employees across the globe work to deliver solutions for patients around the world and to help profoundly impact health for humanity.
“This quarter’s solid financial results and the significant advancement of our pipeline further progressed our business toward future growth,” says Joe Wolk, Executive Vice President and Chief Financial Officer, Johnson & Johnson. “Our strong financial foundation and commitment to operational excellence enables us to continue to invest in innovation that delivers novel treatments for our patients, enhance our portfolio through strategic acquisitions, and return capital for our shareholders, as evidenced by our 62nd consecutive year of dividend increases announced today
For more details about the company’s 2024 first-quarter results and to read a message from Chairman and Chief Executive Officer Joaquin Duato, here’s an infographic highlighting key stats.
Johnson & Johnson’s 2025 first-quarter earnings
Want to see more company earnings information? Find Johnson & Johnson’s past quarterly and full-year results here.
